Calais Philippe 4
4 · Transcode Therapeutics, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Calais Philippe
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-22+9,500→ 9,500 totalExercise: $1.24Exp: 2032-06-21→ Common Stock (9,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.